Revolutionary Treatment Options for Multiple Sclerosis (MS) Symptoms with the Use of CBD Oil
Multiple Sclerosis (MS) is a complicated disorder to which there is no known cure.With symptoms progressively worsening over time, treatment options are essential to combating this complex disease. Promising results have been encouraging with addition of CBD oil to conventional treatments, so much so that the US Department of Health and Human Services (HHS) holds a patent on the use of Cannabinoids (the active chemical compound found CBD) as an antioxidant and neuroprotectant.
SYMPTOMS
The National MS Society Study estimates there to be nearly 1 million people suffering from MS in the United States alone. MS attacks the nerve fibers and disrupts the neurological pathways of the body. This disorder is labeled as an “immune-mediated” condition or in simpler terms an autoimmune disease.
Symptoms often differ from patient to patient but generally diminish the capability to properly perform normal movements, visual disturbances and a variety of other debilitating symptoms. Symptoms may include:
Movement Symptoms
- Tremor & lack of coordination
- Electric shock sensations with the movement of the neck
- Numbness or weakness of the bodily limbs with varying degrees from side to side
Visual Symptoms
- Vision loss
- Double Vision
- Blurred Vision
Other Symptoms
- Fatigue & Dizziness
- Slurred Speech
- Tingling and pain sensations
- Sexual Dysfunction
- Bowel Irregularity
- Bladder Problems
- Changes in bodily temperatures and exacerbate symptoms
THE PROGRESSION OF MS AND ITS SYMPTOMS
MS is characterized by progressively worsening symptoms with periods of relapse. Many relapses can last for months or even years.
HOPE FOR MS PATIENTS
Cannabidiol (CBD) has been shown to manipulate the disrupted neurological pathways that cause the symptoms of MS. Although there is no cure for MS. CBD gives great hope to those who are plagued by its symptoms.
RESEARCH SURROUNDING MULTIPLE SCLEROSIS (MS) WITH CBD AND OTHER CANNABINOIDS
The pivotal research was done in 2007 and in the following years surrounding multiple sclerosis and medical marijuana. I would like to share with you a few that really stuck out.
EUR J NEUROL. 2011
One particular randomized, double-blind study of 241 patients stands out for me. Out of 75% of patients receiving medical cannabis there was relevant improvements in their multiple sclerosis, with only 10% experiencing episodes of sedation and dizziness. 46% of patients also reported improvements in sleep, with 51% reporting reductions in spasm frequency.
EUR J NEUROL. 2016
After marijuana was introduced in Italy, a web-based registry began collecting data on all patients prescribed the medication. 1,534 MS patients had data gathered on them from January 2014 to February 2015. And out of this group, 62% had a robust initial response to adding medical cannabis to their treatments. 41% continued with an ongoing positive response at six months with no evidence of abuse or misuse. This data has been repeated in prospective observational studies in Germany and in Italy in 2014 and 2015.
Further CBD & MS Research can be found at the end of this article.
CHOOSING THE RIGHT CBD FOR MS
The market has some great cannabinoid-based drugs currently available and more on the way. The challenge is to find a drug that is effective for you, the right dosage with an appropriate administration method. There are no set parameters for CBD so it may take some trial and error to find the most effective dosage.
Find a quality compound with a high CBD content. I have seen one dosage containing as much as 250 mg CBD, so do your research, read reviews and use trial and error to find the most suitable CBD product for your body.
It’s important to note that cannabinoids may chemically react with other prescribed drugs, increasing or reducing their effects. So keep a record of any signs or symptoms of a chemical interaction and discontinue usage if symptoms persist.
CONCLUSION
The government’s patent on CBD for the treatment of MS shows what incredible implications this product has been shown to have. But, it does make me wonder why the government hasn’t pursued any clinical trials in the case of CBD. But I digress, many studies have proven the positive effects of CBD in regards to MS and you can confidently choose CBD as an alternative therapy for the treatment of Multiple Sclerosis.
For more information, you can go to:
https://cbdandcannabisinfo.com
Further Research on CBD and Multiple Sclerosis (MS)
- Cannabidiol to Improve Mobility in People with Multiple Sclerosis
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
- Sativex for the management of multiple sclerosis symptoms
- THC & CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
- Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
- CBD provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
- Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
- Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
- Evaluating Sativex in neuropathic pain management
- CBD counteracted the development of experimental MS
- CBD/THC oromucosal spray for multiple sclerosis-related resistant spasticity in daily practice
- Neurological aspects of medical use of CBD
